Yanagisawa, Haruhiko
Department of Pathology,
4 papers on CoChatORCID 0000-0001-9324-3121
Most cited papers
- Verified
Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis
Kobayashi, K., Araya, J., Minagawa, S., Hara, H., Saito, N., Kadota, T., Sato, N., Yoshida, M., Tsubouchi, K., Kurita, Y., et al. (2016) · The Journal of Immunology
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisAutophagy in Disease and Therapy
Cited by 145
- Verified
Integrin αvβ8–expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells
Takasaka, N., Seed, R. I., Cormier, A., Bondesson, A. J., Lou, J., Elattma, A., Ito, S., Yanagisawa, H., Hashimoto, M., Ma, R., et al. (2018) · JCI Insight
TGF-β signaling in diseasesCancer Immunotherapy and Biomarkers
Cited by 119
- Verified
Selective Targeting of TGF-β Activation to Treat Fibroinflammatory Airway Disease
Minagawa, S., Lou, J., Seed, R. I., Cormier, A., Wu, S., Cheng, Y., Murray, L., Tsui, P., Connor, J., Herbst, R., et al. (2014) · Science Translational Medicine
Cell Adhesion Molecules ResearchChronic Obstructive Pulmonary Disease (COPD) Research
Cited by 90
- Verified
Allele-dependent variation in the relative cellular potency of distinct EGFR inhibitors
Yuza, Y., Glatt, K. A., Jiang, J., Greulich, H., Minami, Y., Woo, M. S., Shimamura, T., Shapiro, G. I., Lee, J. C., Ji, H., et al. (2007) · Cancer Biology & Therapy
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 88
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free